Page last updated: 2024-11-07

phosphazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Phosphazines are a class of phosphorus-nitrogen compounds that have attracted significant interest due to their potential applications in various fields. They are characterized by the presence of a P=N double bond within their molecular structure. The synthesis of phosphazines typically involves the reaction of phosphorus-containing compounds with nitrogen-containing reagents. The specific synthetic methods employed vary depending on the desired phosphazine structure and its intended applications. Phosphazines have exhibited a wide range of properties and have been explored for applications in areas such as catalysis, materials science, and medicinal chemistry. Their unique electronic and structural features make them promising candidates for use as catalysts in organic reactions, as components in the development of advanced materials with tailored properties, and as potential drug candidates for the treatment of various diseases. The study of phosphazines continues to be an active area of research, driven by the desire to further understand their properties, explore their potential applications, and develop new synthetic methodologies for their preparation.'

phosphazine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID96661
CHEMBL ID461524
MeSH IDM0053111

Synonyms (27)

Synonym
nsc 84412
phosphimid
phosphinic amide, p,p-bis(1-aziridinyl)-n-2-pyrimidyl-
phosphazine (the pharmaceutical)
p,p-bis(1-aziridinyl)-n-2-pyrimidinyl-phosphinic amide
phosphacin
di(ethylenimide)pirimidyl-2-amido-phosphorous acid
brn 0615892
phosphazine
nsc84412
nsc-84412
phosphemide
phosphinic amide,p-bis(1-aziridinyl)-n-2-pyrimidinyl-
882-58-6
fosfemid
NCIOPEN2_004504
n-[bis(aziridin-1-yl)phosphoryl]pyrimidin-2-amine
CHEMBL461524
5-25-10-00082 (beilstein handbook reference)
phosphinic amide, p,p-bis(1-aziridinyl)-n-2-pyrimidinyl-
6r8r28yp6z ,
unii-6r8r28yp6z
di(ethylenimide)pyrimidyl-2-amido-phosphorous acid
phosphorotriamide, n-(2-pyrimidyl)-n1,n2-di(ethylene)-
Q27265376
p,p-bis[(aziridin-1-yl)]-n-pyrimidin-2-ylphosphinic amide
DTXSID901007993

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"It is shown that under the influence of phosphemide in combination with dexamethasone some characteristics of tumour DNA (content of 5 methyl cytosine, temperature, interval and enthalpy of melting) approximate the corresponding characteristics of DNA of healthy animals' liver better than under the influence of phosphemide only."( [Effect of phosphemide in combination with dexamethasone on DNA structure in sarcoma 45].
Ananian, GV; Aslanian, LL; Babaian, IuS; Garibian, DV,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (36.36)18.2507
2000's4 (36.36)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.53 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index72.10 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (47.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]